Afuco™ Anti-SELP ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-246) (CAT#: AFC-TAB-246)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to selectin P. It is a humanized monoclonal that binds to selectin P.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • CD62P transfected 300.19 cells (Human)
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • ELISA, FC, IP, FuncS, IF, Neut
  • Conjugate
  • Unconjugated
  • Generic Name
  • Inclacumab
  • Related Disease
  • Myocardial infection

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • SELP; selectin P (granule membrane protein 140kDa, antigen CD62); GRMP, selectin P (granule membrane protein 140kD, antigen CD62); P-selectin; CD62; CD62P; GMP140; PADGEM; PSEL; GMP-140

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Inclacumab"

Anti-Human selectin P Recombinant Antibody (Inclacumab)
Recombinant monoclonal antibody to selectin P. Inclacumab (INN) is a humanized monoclonal that binds to selectin P.
DrugMonitor™ Anti-Inclacumab Antibody (VS-1224-YC598)
Inclacumab is a fully human IgG4 monoclonal antibody targeting P-selectin, studied in trials for myocardial infarction, peripheral arterial disease (PAD), coronary heart disease, graft occlusion, and vascular conditions. The DrugMonitor™ Anti-Inclacumab Antibody (VS-1224-YC598) is an anti-drug antibody (ADA) against Inclacumab. This drug-based antibody is raised in mice immunized with the Inclacumab. The anti-Inclacumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Inclacumab in samples.

See other products for "SELP"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products Mouse Antibody Products Humanized Antibody Products IgG Antibody Products Blocking Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products ScFv Antibody Products Flow Cytometry (FC) related Products
CAT Product Name Application Type
TAB-246 Anti-Human selectin P Recombinant Antibody (Inclacumab) ELISA, FC, IP, FuncS, IF, Neut, ICC IgG4 - kappa

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-246. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare